[144] ABBVIE INC. SEC Filing
AbbVie Inc. (ABBV) Form 144 notice: An insider proposes to sell 62,755 shares of common stock through Morgan Stanley Smith Barney LLC on 08/22/2025. The shares were acquired the same day via a stock option exercise and paid for in cash. The filing lists an aggregate market value for the proposed sale of $13,231,264.20 and reports 1,766,558,253 shares outstanding for the class. The filer also reported four prior common-stock sales in August 2025 by Richard A. Gonzalez: 61,500 shares on 08/01/2025 (gross proceeds $12,043,268.25), 35,120 shares and 91,600 shares on 08/04/2025 (gross proceeds $6,828,296.22 and $19,208,000.00 respectively), and 90,000 shares on 08/21/2025 (gross proceeds $18,993,947.76). The filer certifies no undisclosed material adverse information and acknowledges legal penalties for false statements.
Avviso Form 144 di AbbVie Inc. (ABBV): Un insider intende vendere 62.755 azioni ordinarie tramite Morgan Stanley Smith Barney LLC in data 22/08/2025. Le azioni sono state acquisite lo stesso giorno tramite un esercizio di opzione su azioni e pagate in contanti. La comunicazione indica un valore di mercato complessivo della vendita proposta pari a $13.231.264,20 e riporta 1.766.558.253 azioni in circolazione per la classe. Il dichiarante segnala inoltre quattro precedenti vendite di azioni ordinarie ad agosto 2025 da parte di Richard A. Gonzalez: 61.500 azioni il 01/08/2025 (proventi lordi $12.043.268,25), 35.120 azioni e 91.600 azioni il 04/08/2025 (proventi lordi rispettivamente $6.828.296,22 e $19.208.000,00), e 90.000 azioni il 21/08/2025 (proventi lordi $18.993.947,76). Il dichiarante certifica l'assenza di informazioni materiali non divulgate e prende atto delle sanzioni legali previste per dichiarazioni false.
Aviso Form 144 de AbbVie Inc. (ABBV): Un insider propone vender 62.755 acciones ordinarias a trav茅s de Morgan Stanley Smith Barney LLC el 22/08/2025. Las acciones fueron adquiridas el mismo d铆a mediante un ejercicio de opci贸n sobre acciones y pagadas en efectivo. La presentaci贸n indica un valor de mercado agregado de la venta propuesta de $13.231.264,20 y reporta 1.766.558.253 acciones en circulaci贸n para la clase. El declarante tambi茅n inform贸 cuatro ventas previas de acciones ordinarias en agosto de 2025 por parte de Richard A. Gonzalez: 61.500 acciones el 01/08/2025 (ingresos brutos $12.043.268,25), 35.120 y 91.600 acciones el 04/08/2025 (ingresos brutos $6.828.296,22 y $19.208.000,00 respectivamente), y 90.000 acciones el 21/08/2025 (ingresos brutos $18.993.947,76). El presentador certifica que no existen informaciones materiales no divulgadas y reconoce las sanciones legales por declaraciones falsas.
AbbVie Inc. (ABBV) Form 144 瓿奠嫓: 雮措秬鞛愱皜 Morgan Stanley Smith Barney LLC毳� 韱淀暣 62,755 欤检潣 氤错喌欤茧ゼ 2025-08-22鞐� 毵り皝頃� 鞓堨爼鞛呺媹雼�. 頃措嫻 欤检嫕鞚� 臧欖潃 雮� 鞀ろ啞鞓奠厴 頄夓偓搿� 旆摑霅橃柎 順勱笀鞙茧 瓴办牅霅橃棃鞀惦媹雼�. 鞁犼碃靹滊姅 鞝滌晥霅� 毵り皝鞚� 齑� 鞁滉皜毳� $13,231,264.20鞙茧 旮办灛頃橁碃 頃措嫻 韥措灅鞀れ潣 氚滍枆欤检嫕靾橂ゼ 1,766,558,253欤茧 氤搓碃頃橁碃 鞛堨姷雼堧嫟. 鞁犼碃鞚胳潃 霕愴暅 Richard A. Gonzalez臧� 2025雲� 8鞗旍棎 鞁れ嫓頃� 鞚挫爠 氤错喌欤� 毵り皝 4瓯挫潉 氤搓碃頄堨姷雼堧嫟: 2025-08-01鞐� 61,500欤�(齑濎垬鞛� $12,043,268.25), 2025-08-04鞐� 35,120欤� 氚� 91,600欤�(齑濎垬鞛� 臧侁皝 $6,828,296.22 氚� $19,208,000.00), 2025-08-21鞐� 90,000欤�(齑濎垬鞛� $18,993,947.76). 鞁犼碃鞚胳潃 氙戈车臧� 欷戩殧 鞝曤炒臧� 鞐嗢潓鞚� 歃濍獏頃橂┌ 項堨渼 歆勳垹鞐� 雽�頃� 氩曥爜 觳橂矊鞚� 鞚胳頃滊嫟瓿� 氇呾嫓頄堨姷雼堧嫟.
Avis Form 144 d'AbbVie Inc. (ABBV) : Un initi茅 propose de vendre 62 755 actions ordinaires via Morgan Stanley Smith Barney LLC le 22/08/2025. Les actions ont 茅t茅 acquises le m锚me jour par exercice d'option sur actions et r茅gl茅es en esp猫ces. Le dossier indique une valeur de march茅 agr茅g茅e de la vente propos茅e de 13 231 264,20 $ et rapporte 1 766 558 253 actions en circulation pour la cat茅gorie. Le d茅clarant signale 茅galement quatre ventes ant茅rieures d'actions ordinaires en ao没t 2025 par Richard A. Gonzalez : 61 500 actions le 01/08/2025 (produits bruts 12 043 268,25 $), 35 120 et 91 600 actions le 04/08/2025 (produits bruts respectifs 6 828 296,22 $ et 19 208 000,00 $), et 90 000 actions le 21/08/2025 (produits bruts 18 993 947,76 $). Le d茅clarant certifie l'absence d'informations mat茅rielles non divulgu茅es et reconna卯t les sanctions l茅gales en cas de fausses d茅clarations.
Form 144-Mitteilung von AbbVie Inc. (ABBV): Ein Insider beabsichtigt, am 22.08.2025 眉ber Morgan Stanley Smith Barney LLC 62.755 Stammaktien zu ver盲u脽ern. Die Aktien wurden am selben Tag durch Aus眉bung einer Aktienoption erworben und bar bezahlt. Die Einreichung nennt einen Gesamtmarktwert der geplanten Ver盲u脽erung von $13.231.264,20 und meldet 1.766.558.253 ausstehende Aktien dieser Klasse. Der Einreicher berichtet zudem 眉ber vier fr眉here Stammaktienverk盲ufe im August 2025 durch Richard A. Gonzalez: 61.500 Aktien am 01.08.2025 (Bruttoerl枚s $12.043.268,25), 35.120 und 91.600 Aktien am 04.08.2025 (Bruttoerl枚se $6.828.296,22 bzw. $19.208.000,00) sowie 90.000 Aktien am 21.08.2025 (Bruttoerl枚s $18.993.947,76). Der Einreicher best盲tigt, dass keine nicht offengelegten wesentlichen Informationen vorliegen, und erkennt die rechtlichen Sanktionen f眉r falsche Angaben an.
- Transaction fully documented: Broker, acquisition method (stock option exercise), payment (cash), and proposed sale date are provided
- Insider attestation present: Signature block includes representation of no undisclosed material adverse information
- Insider sales volume: Multiple sizable sales in August 2025 totaling 288,220 shares by the same person may be viewed negatively by some investors
- Concentration of sales: Prior gross proceeds reported exceed $56 million across four transactions, indicating substantial insider liquidity
Insights
TL;DR: Insider exercised options and filed to sell 62,755 AbbVie shares; several sizable August sales were reported.
The filing documents a routine Rule 144 notice for sale of common shares following a stock option exercise and immediate cash payment. The proposed transaction is routed through Morgan Stanley Smith Barney LLC and the reported aggregate market value of the intended sale is $13.23 million. Recent August activity shows multiple block sales by the same individual, totaling 288,220 shares across four transactions, producing reported gross proceeds exceeding $56 million. For investors, this is a disclosure of insider liquidity rather than operational or financial performance information; it does not, by itself, indicate company-level changes.
TL;DR: Filing appears to comply with Rule 144 disclosure requirements and includes standard insider attestation.
The notice includes required details: broker, number of shares, acquisition method, payment type, and prior three-month sales. The signer affirms there is no undisclosed material adverse information and notes potential criminal penalties for false statements. No conflicting information or procedural irregularities are evident in the provided text. Any compliance risk would depend on timeliness and accuracy relative to underlying records, which are not provided here.
Avviso Form 144 di AbbVie Inc. (ABBV): Un insider intende vendere 62.755 azioni ordinarie tramite Morgan Stanley Smith Barney LLC in data 22/08/2025. Le azioni sono state acquisite lo stesso giorno tramite un esercizio di opzione su azioni e pagate in contanti. La comunicazione indica un valore di mercato complessivo della vendita proposta pari a $13.231.264,20 e riporta 1.766.558.253 azioni in circolazione per la classe. Il dichiarante segnala inoltre quattro precedenti vendite di azioni ordinarie ad agosto 2025 da parte di Richard A. Gonzalez: 61.500 azioni il 01/08/2025 (proventi lordi $12.043.268,25), 35.120 azioni e 91.600 azioni il 04/08/2025 (proventi lordi rispettivamente $6.828.296,22 e $19.208.000,00), e 90.000 azioni il 21/08/2025 (proventi lordi $18.993.947,76). Il dichiarante certifica l'assenza di informazioni materiali non divulgate e prende atto delle sanzioni legali previste per dichiarazioni false.
Aviso Form 144 de AbbVie Inc. (ABBV): Un insider propone vender 62.755 acciones ordinarias a trav茅s de Morgan Stanley Smith Barney LLC el 22/08/2025. Las acciones fueron adquiridas el mismo d铆a mediante un ejercicio de opci贸n sobre acciones y pagadas en efectivo. La presentaci贸n indica un valor de mercado agregado de la venta propuesta de $13.231.264,20 y reporta 1.766.558.253 acciones en circulaci贸n para la clase. El declarante tambi茅n inform贸 cuatro ventas previas de acciones ordinarias en agosto de 2025 por parte de Richard A. Gonzalez: 61.500 acciones el 01/08/2025 (ingresos brutos $12.043.268,25), 35.120 y 91.600 acciones el 04/08/2025 (ingresos brutos $6.828.296,22 y $19.208.000,00 respectivamente), y 90.000 acciones el 21/08/2025 (ingresos brutos $18.993.947,76). El presentador certifica que no existen informaciones materiales no divulgadas y reconoce las sanciones legales por declaraciones falsas.
AbbVie Inc. (ABBV) Form 144 瓿奠嫓: 雮措秬鞛愱皜 Morgan Stanley Smith Barney LLC毳� 韱淀暣 62,755 欤检潣 氤错喌欤茧ゼ 2025-08-22鞐� 毵り皝頃� 鞓堨爼鞛呺媹雼�. 頃措嫻 欤检嫕鞚� 臧欖潃 雮� 鞀ろ啞鞓奠厴 頄夓偓搿� 旆摑霅橃柎 順勱笀鞙茧 瓴办牅霅橃棃鞀惦媹雼�. 鞁犼碃靹滊姅 鞝滌晥霅� 毵り皝鞚� 齑� 鞁滉皜毳� $13,231,264.20鞙茧 旮办灛頃橁碃 頃措嫻 韥措灅鞀れ潣 氚滍枆欤检嫕靾橂ゼ 1,766,558,253欤茧 氤搓碃頃橁碃 鞛堨姷雼堧嫟. 鞁犼碃鞚胳潃 霕愴暅 Richard A. Gonzalez臧� 2025雲� 8鞗旍棎 鞁れ嫓頃� 鞚挫爠 氤错喌欤� 毵り皝 4瓯挫潉 氤搓碃頄堨姷雼堧嫟: 2025-08-01鞐� 61,500欤�(齑濎垬鞛� $12,043,268.25), 2025-08-04鞐� 35,120欤� 氚� 91,600欤�(齑濎垬鞛� 臧侁皝 $6,828,296.22 氚� $19,208,000.00), 2025-08-21鞐� 90,000欤�(齑濎垬鞛� $18,993,947.76). 鞁犼碃鞚胳潃 氙戈车臧� 欷戩殧 鞝曤炒臧� 鞐嗢潓鞚� 歃濍獏頃橂┌ 項堨渼 歆勳垹鞐� 雽�頃� 氩曥爜 觳橂矊鞚� 鞚胳頃滊嫟瓿� 氇呾嫓頄堨姷雼堧嫟.
Avis Form 144 d'AbbVie Inc. (ABBV) : Un initi茅 propose de vendre 62 755 actions ordinaires via Morgan Stanley Smith Barney LLC le 22/08/2025. Les actions ont 茅t茅 acquises le m锚me jour par exercice d'option sur actions et r茅gl茅es en esp猫ces. Le dossier indique une valeur de march茅 agr茅g茅e de la vente propos茅e de 13 231 264,20 $ et rapporte 1 766 558 253 actions en circulation pour la cat茅gorie. Le d茅clarant signale 茅galement quatre ventes ant茅rieures d'actions ordinaires en ao没t 2025 par Richard A. Gonzalez : 61 500 actions le 01/08/2025 (produits bruts 12 043 268,25 $), 35 120 et 91 600 actions le 04/08/2025 (produits bruts respectifs 6 828 296,22 $ et 19 208 000,00 $), et 90 000 actions le 21/08/2025 (produits bruts 18 993 947,76 $). Le d茅clarant certifie l'absence d'informations mat茅rielles non divulgu茅es et reconna卯t les sanctions l茅gales en cas de fausses d茅clarations.
Form 144-Mitteilung von AbbVie Inc. (ABBV): Ein Insider beabsichtigt, am 22.08.2025 眉ber Morgan Stanley Smith Barney LLC 62.755 Stammaktien zu ver盲u脽ern. Die Aktien wurden am selben Tag durch Aus眉bung einer Aktienoption erworben und bar bezahlt. Die Einreichung nennt einen Gesamtmarktwert der geplanten Ver盲u脽erung von $13.231.264,20 und meldet 1.766.558.253 ausstehende Aktien dieser Klasse. Der Einreicher berichtet zudem 眉ber vier fr眉here Stammaktienverk盲ufe im August 2025 durch Richard A. Gonzalez: 61.500 Aktien am 01.08.2025 (Bruttoerl枚s $12.043.268,25), 35.120 und 91.600 Aktien am 04.08.2025 (Bruttoerl枚se $6.828.296,22 bzw. $19.208.000,00) sowie 90.000 Aktien am 21.08.2025 (Bruttoerl枚s $18.993.947,76). Der Einreicher best盲tigt, dass keine nicht offengelegten wesentlichen Informationen vorliegen, und erkennt die rechtlichen Sanktionen f眉r falsche Angaben an.
FAQ
What does AbbVie (ABBV) Form 144 filed on 08/22/2025 report?
Who is the seller identified in the Form 144 for ABBV?
What prior sales by the insider are reported in the past three months?
How many shares outstanding does the Form 144 list for AbbVie's class?
Does the Form 144 include any indication of undisclosed material information?
